Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,989
Total Claims
$502K
Drug Cost
261
Beneficiaries
$1,923
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+15%
Opioid rate vs peers
4.3% vs 3.8% avg
+64%
Cost per patient vs peers
$1,923 vs $1,174 avg
+51%
Brand preference vs peers
13.4% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.3%
Opioid Rate
217
Opioid Claims
$3,130
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 663 claims · $418K
Generic: 4,291 claims · $82K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 38 | $37K |
| Semaglutide | 37 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 40 | $33K |
| Tiotropium Bromide | 31 | $20K |
| Lurasidone Hcl | 14 | $20K |
| Empagliflozin | 18 | $18K |
| Linagliptin | 20 | $18K |
| Tiotropium Bromide | 11 | $16K |
| Galcanezumab-Gnlm | 22 | $15K |
| Insulin Nph Hum/Reg Insulin Hm | 11 | $11K |
| Linaclotide | 16 | $11K |
| Colesevelam Hcl | 30 | $9,583 |
| Budesonide/Formoterol Fumarate | 15 | $8,102 |
| Insulin Lispro | 12 | $7,759 |
| Umeclidinium Bromide | 12 | $5,950 |
Prescribing Profile
Patient Profile
67
Avg Age
72%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About